Collplant Biotechnologies LTCLGN
13F holders, Q2 2025 (June 30)17holders +2
4new positions
2sold out
1famous investor
$1.35avg. 13F price*
At the end of Q2 2025, 17 institutions reported holding Collplant Biotechnologies LT (CLGN) in their 13F filings, up 2 from Q1 2025. 4 opened new positions and 2 sold out. The largest holders were Villere St Denis J & Co. LLC ($744K), Pinnacle Associates Ltd. ($690K) and Heights Capital Management, Inc. ($377K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Collplant Biotechnologies LT
- CUSIP
- M2R51X116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $608K |
| Exits | 2 | $63K |
All 13F filers, Q1 2025 → Q2 2025: 611,074 shares bought and 24,658 shares sold, net +586,416 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Villere St Denis J & Co. LLC | 0.07% | Add +13.0% | 546,867 | $744K |
| Pinnacle Associates Ltd. | 0.01% | Add +3.7% | 507,193 | $690K |
| Heights Capital Management, Inc. | 0.12% | New | 275,082 | $377K |
| AMH Equity Ltd | 0.32% | Add +28.7% | 160,849 | $219K |
| Anson Funds Management LP | 0.04% | New | 159,401 | $217K |
| Brown Advisory Inc. | 0.00% | Reduce -0.0% | 111,181 | $151K |
| Renaissance Technologies | 0.00% | Add +303.9% | 41,600 | $57K |
| Pathstone Holdings, LLC | 0.00% | Add +100.0% | 34,000 | $23K |
| Waters Parkerson & Co., LLC | 0.00% | No change | 13,250 | $18K |
| Wells Fargo & Company | 0.00% | Add +8.8% | 12,405 | $17K |
| Two Sigma Securities, LLC | 0.00% | New | 10,349 | $14K |
| Bank of America Corp. | 0.00% | No change | 2,500 | $3K |
| Osaic Holdings, Inc. | 0.00% | Reduce -16.3% | 335 | $455 |
| National Bank of Canada | 0.00% | No change | 250 | $338 |
| SBI Securities Co., Ltd. | 0.00% | No change | 200 | $272 |
| Morgan Stanley | 0.00% | No change | 1 | $3 |
| Simplex Trading, LLC | 0.00% | New | 93 | $0 |
"% of holder's portfolio" is CLGN's weight in each manager's 13F, not the share of Collplant Biotechnologies LT the manager owns.